Fast Five Quiz: Type 2 Diabetes and Dyslipidemia

Anne L. Peters, MD

Disclosures

May 16, 2022

Bile acid sequestrants bind with bile acids in the intestines, preventing the reabsorption of bile acids. They reduce LDL levels by approximately 15%-30%. Studies have demonstrated that cholestyramine may decrease cardiovascular mortality and morbidity by 19% compared with patients on placebo. In addition, bile acid sequestrants can reduce blood sugar levels, benefiting patients with type 2 diabetes.

Fibrates and nicotinic acid may raise high-density lipoprotein cholesterol levels but have not been shown to improve cardiovascular outcomes in patients on statins. Similarly, the STRENGTH trial found no benefit in fish oil supplementation in the incidence of major adverse cardiovascular events in high-risk patients.

Learn more about type 2 diabetes.

Comments

3090D553-9492-4563-8681-AD288FA52ACE
Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.

processing....